New York-headquartered health insurance company, Oscar Health is seeing a dip in its Momentum score in Benzinga's Edge Stock Rankings.

Oscar Health, Inc. (OSCR) concluded the recent trading session at $14.84, signifying a -1.26% move from its prior day's close.

Shares of Coupang and Oscar Health have good chances of bouncing back in 2026. Improved profit margins for the e-commerce giant should continue into 2026.

In this video, I will discuss two undervalued companies that have experienced a decent pullback in 2025 and expect to show fundamental improvements in 2026. Watch the short video to learn more, consider subscribing, and click the special offer link below.

Oscar Health, Inc. (OSCR) reached $15.71 at the closing of the latest trading day, reflecting a -2.66% change compared to its last close.

From a technical perspective, Oscar Health, Inc. (OSCR) is looking like an interesting pick, as it just reached a key level of support. OSCR recently overtook the 200-day moving average, and this suggests a long-term bullish trend.

Elizabeth Warren slams GOP for blocking ACA subsidies, warning of spiking healthcare costs and leaving American families "in the dirt."

The latest trading day saw Oscar Health, Inc. (OSCR) settling at $15.59, representing a -8.08% change from its previous close.

Oscar Health's (OSCR +1.31%) management team is planning big price increases in 2026 to offset higher costs.

Oscar Health is rerated as a bullish pick, driven by ACA enrollment expansion into Alabama, Southern Florida, and other high-growth regions. OSCR projects a 2027 market reach of 24 million members without subsidies and 31 million with subsidies, supporting robust revenue growth. Despite regulatory uncertainty around ACA subsidies expiring after 2025, OSCR's expansion, affordable plans, and innovative offerings position it well for membership growth.